414 related articles for article (PubMed ID: 15001531)
1. Evidence for fusion between cardiac and skeletal muscle cells.
Reinecke H; Minami E; Poppa V; Murry CE
Circ Res; 2004 Apr; 94(6):e56-60. PubMed ID: 15001531
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
[TBL] [Abstract][Full Text] [Related]
3. Avian precardiac endoderm/mesoderm induces cardiac myocyte differentiation in murine embryonic stem cells.
Rudy-Reil D; Lough J
Circ Res; 2004 Jun; 94(12):e107-16. PubMed ID: 15192018
[TBL] [Abstract][Full Text] [Related]
4. Myotube driven myogenic recruitment of cells during in vitro myogenesis.
Breton M; Li ZL; Paulin D; Harris JA; Rieger F; Pinçon-Raymond M; Garcia L
Dev Dyn; 1995 Feb; 202(2):126-36. PubMed ID: 7734731
[TBL] [Abstract][Full Text] [Related]
5. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
[TBL] [Abstract][Full Text] [Related]
6. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles.
Pin CL; Merrifield PA
Dev Biol; 1997 Aug; 188(1):147-66. PubMed ID: 9245519
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting.
Reinecke H; Poppa V; Murry CE
J Mol Cell Cardiol; 2002 Feb; 34(2):241-9. PubMed ID: 11851363
[TBL] [Abstract][Full Text] [Related]
9. Fusion of bone marrow-derived stem cells with cardiomyocytes in a heterologous in vitro model.
Garbade J; Schubert A; Rastan AJ; Lenz D; Walther T; Gummert JF; Dhein S; Mohr FW
Eur J Cardiothorac Surg; 2005 Nov; 28(5):685-91. PubMed ID: 16194609
[TBL] [Abstract][Full Text] [Related]
10. Green fluorescent protein incorporation by mouse myoblasts may yield false evidence of myogenic differentiation of human haematopoietic stem cells.
Di Castro A; Bonci D; Musumeci M; Grassi F
Acta Physiol (Oxf); 2008 Jul; 193(3):249-56. PubMed ID: 18284377
[TBL] [Abstract][Full Text] [Related]
11. Contribution of human bone marrow stem cells to individual skeletal myotubes followed by myogenic gene activation.
Lee JH; Kosinski PA; Kemp DM
Exp Cell Res; 2005 Jul; 307(1):174-82. PubMed ID: 15922737
[TBL] [Abstract][Full Text] [Related]
12. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
Yu YA; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
[TBL] [Abstract][Full Text] [Related]
13. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells.
Payne TR; Oshima H; Sakai T; Ling Y; Gharaibeh B; Cummins J; Huard J
Gene Ther; 2005 Aug; 12(16):1264-74. PubMed ID: 15843810
[TBL] [Abstract][Full Text] [Related]
14. The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice.
De Repentigny Y; Marshall P; Worton RG; Kothary R
Hum Mol Genet; 2004 Nov; 13(22):2853-62. PubMed ID: 15385445
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantation.
Del Bo R; Torrente Y; Corti S; D'Angelo MG; Comi GP; Fagiolari G; Salani S; Cova A; Pisati F; Moggio M; Ausenda C; Scarlato G; Bresolin N
Cell Transplant; 2001; 10(2):209-21. PubMed ID: 11332636
[TBL] [Abstract][Full Text] [Related]
16. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
[TBL] [Abstract][Full Text] [Related]
17. Specific monitoring of cardiomyogenic and endothelial differentiation by dual promoter-driven reporter systems in bone marrow mesenchymal stem cells.
Choi SC; Shim WJ; Lim DS
Biotechnol Lett; 2008 May; 30(5):835-43. PubMed ID: 18175067
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle.
Matsuura K; Wada H; Nagai T; Iijima Y; Minamino T; Sano M; Akazawa H; Molkentin JD; Kasanuki H; Komuro I
J Cell Biol; 2004 Oct; 167(2):351-63. PubMed ID: 15492039
[TBL] [Abstract][Full Text] [Related]
19. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice.
Hattan N; Kawaguchi H; Ando K; Kuwabara E; Fujita J; Murata M; Suematsu M; Mori H; Fukuda K
Cardiovasc Res; 2005 Feb; 65(2):334-44. PubMed ID: 15639472
[TBL] [Abstract][Full Text] [Related]
20. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
